AnaptysBio (NASDAQ:ANAB – Free Report) had its price target boosted by Wells Fargo & Company from $40.00 to $51.00 in a report issued on Thursday,Benzinga reports. Wells Fargo & Company currently has ...
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) has received a consensus recommendation of “Hold” from the ten ...
Verywell Health on MSN18h
Working Out Regularly Could Lower Your Risk of Dementia, Study FindsA poor response to insulin can lead to dementia, so the idea that exercise can help prevent this by possibly boosting insulin ...
GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Eric Jonasch discussing a phase 1b/2 study of combination 177Lu girentuximab + cabozantinib and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback